Literature DB >> 3820153

Inappropriate prescribing in the elderly.

K R Adams, S Al-Hamouz, E Edmund, R C Tallis, C Vellodi, M Lye.   

Abstract

Mesh:

Year:  1987        PMID: 3820153      PMCID: PMC5379429     

Source DB:  PubMed          Journal:  J R Coll Physicians Lond        ISSN: 0035-8819


× No keyword cloud information.
  11 in total

Review 1.  Electrolyte disorders in the elderly.

Authors:  K R Adams; J A Martin
Journal:  Drugs Aging       Date:  1991 Jul-Aug       Impact factor: 3.923

2.  Rates and costs of prescribing.

Authors: 
Journal:  Occas Pap R Coll Gen Pract       Date:  1991-11

3.  Avoiding drug errors. Inappropriate prescribing is "treatable".

Authors:  R C Tallis
Journal:  BMJ       Date:  1995-11-18

Review 4.  Preventing drug reactions in the elderly: can we do better?

Authors:  R C Tallis
Journal:  J R Soc Med       Date:  1994       Impact factor: 5.344

5.  Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta.

Authors:  D B Hogan; N R Campbell; R Crutcher; P Jennett; N MacLeod
Journal:  CMAJ       Date:  1994-08-01       Impact factor: 8.262

Review 6.  Drug dosage in the elderly. Is it rational?

Authors:  K Turnheim
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

Review 7.  Digoxin toxicity in the aged. Characterising and avoiding the problem.

Authors:  A P Passmore; G D Johnston
Journal:  Drugs Aging       Date:  1991 Sep-Oct       Impact factor: 3.923

Review 8.  Adverse drug reactions. An overview of special considerations in the management of the elderly patient.

Authors:  L A Brawn; C M Castleden
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

Review 9.  Visual hallucinations in the elderly associated with the use of levodopa.

Authors:  A K Banerjee; P G Falkai; M Savidge
Journal:  Postgrad Med J       Date:  1989-06       Impact factor: 2.401

Review 10.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  S Dawling; P Crome
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.